Cardiology Device Lobbyists Focused On Reimbursement, Coronavirus, Trade Issues In Early 2020
Industry lobbyists include former legislators, key committee staffers, say lobby reports
Executive Summary
Cardiology device firms relied primarily on in-house lobbyists but also recruited external groups to sway lawmakers to adopt favorable positions on reimbursement, COVID-19, international trade and other issues from January-March 2020, says this Medtech Insight analysis.